Sequenom Shares Continue Slide | GenomeWeb
Shares in Sequenom dropped 11.3 percent for the five-day trading period ended Tuesday. It marked the third week in a row the firm’s shares have declined, and followed last week’s 9.2 percent drop. There had been no recent news regarding the company — though it did report after Tuesday that it had received commitments from institutional investors to buy a total of 6,666,666 shares of Sequenom for $3 per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.